Publisher Correction: Autophagy promotes growth of tumors with high mutational burden by inhibiting a T-cell immune response

Nat Cancer. 2021 Sep;2(9):994. doi: 10.1038/s43018-021-00252-2.

Laura Poillet-Perez¹, Daniel W Sharp¹, Yang Yang¹, Saurabh V Laddha¹, Maria Ibrahim¹, Praveen K Bommareddy^{1

2}, Zhixian Sherrie Hu¹, Joshua Vieth¹, Michael Haas³, Marcus W Bosenberg⁴, Joshua D Rabinowitz^{1

5}, Jian Cao^{1

6}, Jun-Lin Guan³, Shridar Ganesan^{1

6}, Chang S Chan^{1

6}, Janice M Mehnert^{1

6}, Edmund C Lattime^{1

7}, Eileen White^{8

9}

¹ Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
² Replimune Inc., Woburn, MA, USA.
³ Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
⁴ Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.
⁵ Department of Chemistry and Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA.
⁶ Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA.
⁷ Department of Surgery, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA.
⁸ Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. epwhite@cinj.rutgers.edu.
⁹ Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, NJ, USA. epwhite@cinj.rutgers.edu.

No abstract available

Publication types